EHA 2016: When will the daratumumab triplet combination be approved for multiple myeloma?

Antonio Palumbo, MD from the University of Turin, Turin, Italy talks about when daratumumab will be available in combination with bortezomib and dexamethasone or lenalidomide and dexamethasone. Daratu... Author: VJHemOnc Added: 06/24/2016
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts